DECIPHERA PHARMACEUTICALS, LLC SECOND AMENDED & RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 11th, 2017 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 26th day of May, 2017, by and among Deciphera Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”) and the successor in interest to Deciphera Pharmaceuticals, LLC, a Kansas limited liability company, each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”. Reference is hereby made to the Company’s Third Amended and Restated Operating Agreement, dated as of even date herewith, by and among the parties named therein, as such agreement may be amended from time to time (the “Operating Agreement”).
